GLOBAL BIOSCIENCES DEALMAKERS: 30+ YEARS. 300+ CLIENTS & DEALS. BILLIONS IN VALUE.
About Sage
Sage are leaders in the provision of transactional and strategic advice to companies in the healthcare and life science sectors.
​
Sage Healthcare is a global healthcare transaction advisory firm focused exclusively on life sciences. We work with pharmaceutical, biotechnology, medical technology, diagnostics and advanced therapy companies to execute licensing, partnering, M&A and strategic transactions.
​
Our principals have led more than 200 multinational transactions across the United States, Europe, Japan, China, Australia, the Middle East and Latin America, covering assets from early clinical stage through to global commercial products.
​
Unlike generalist investment banks or consulting firms, Sage operates as a highly specialised transaction platform. We combine deep sector expertise, direct access to corporate decision-makers, and proprietary AI-driven analytics to identify, qualify and close the right transactions for our clients.
​
Sage maintains offices and affiliated teams across North America, Europe, Israel and Asia-Pacific, allowing us to operate continuously across time zones and cultures and to engage decision-makers in their local markets.
​
Sector Focus
We work exclusively with healthcare-focused organizations across a broad range of bio-industry segments, including:
-
Pharmaceuticals
-
Biotechnology
-
Cell and Gene Therapy
-
Diagnostics and Digital Biomarkers
-
Medical Devices and Medical Technology
-
Regenerative Medicine
-
Analytical Instrumentation
-
Veterinary Health
-
AI-enabled Drug Discovery and Tech-Bio Platforms
​